Nucleic acid therapeutic carriers with on-demand triggered release

Bioconjugate Chemistry

Volumn 20, Issue 9, 2009, Pages 1773-1782

  Venkatesh, Siddarth ^a   Wower, Jacek ^b   Byrne, Mark E ^a  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; FUNCTIONAL POLYMERS; GENE TRANSFER; GENES; HYDROGELS; MELTING; NUCLEIC ACIDS; OLIGONUCLEOTIDES; TARGETED DRUG DELIVERY;

ARTIFICIAL MATERIAL; BIO-HYBRIDS; CROSS LINKING; GENE DELIVERY; OLIGONUCLEOTIDE SEQUENCES; ON DEMANDS; POLYMER NETWORKS; RELEASE PROFILES; SYNTHETIC POLYMERS; TRIGGERED RELEASE;

DIFFUSION;

ACRYLIC ACID; COPOLYMER; DEOXYRIBOZYME; MESSENGER RNA; NUCLEIC ACID; OLIGONUCLEOTIDE; POLYMER; RESTRICTION ENDONUCLEASE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; CROSS LINKING; DIFFUSION; DIFFUSION COEFFICIENT; ENZYME SPECIFICITY; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROMOLECULE; MELTING POINT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEIC ACID IMMOBILIZATION; NUCLEOTIDE SEQUENCE; TEMPERATURE; VIRAL GENE DELIVERY SYSTEM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70349216639     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900187b     Document Type: Article

References (87)

1. Stevenson, M. (2003) Dissecting HIV-1 through RNA interference. Nat. Rev. Immunol. 3, 851-858.
2. Vane, J. R. (1976) The mode of action of aspirin and similar compounds. J. Allergy Clin. Immunol. 58, 691-712.
3. Black, J. W., and Prichard, B. N. (1973) Activation and blockade of beta adrenoceptors in common cardiac disorders. Br. Med. Bull. 29, 163-167
4. Fedor, M. J., and Williamson, J. R. (2005) The catalytic diversity of RNAs. Nat. Rev. Mol. Cell Biol. 6, 399-412.
5. Kim, D. H., and Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184
6. Serganov, A., and Patel, D. J. (2007) Ribozymes, riboswitches and beyond: regulation of gene expression without proteins. Nat. Rev. Genet. 8, 776-790 (Pubitemid 47429208)
7. Tuerk, C., and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (Pubitemid 20248891)
8. Ellington, A. D., and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822 (Pubitemid 20272100)
9. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., and Stoffel, M. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685.
10. Castanotto, D., and Rossi, J. J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433
11. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discovery 8, 129-138
12. Bumcrot, D., Manoharan, M., Koteliansky, V., and Sah, D. W. Y. (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711-719. (Pubitemid 44764213)
13. Choi, Y., Thomas, T., Kotlyar, A., Islam, M. T., and Baker, J. R., Jr. (2005) Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem. Biol. 12, 35-43.
14. Zhang, K., Wang, Q., Xie, Y., Mor, G., Sega, E., Low, P. S., and Huang, Y. (2008) Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. RNA 14, 577-583
15. Langer, R., and Peppas, N. A. (2003) Advances in biomaterials, drug delivery, and bionanotechnology. AlChE J. 49, 2990-3006. (Pubitemid 38009884)
16. Venkatesh, S., Byrne, M. E., Peppas, N. A., and Hilt, J. Z. (2005) Applications of biomimetic systems in drug delivery. Exp. Opin. Drug Delivery 2, 1085-1096 (Pubitemid 41701206)
17. Pack, D. W., Hoffman, A. S., Pun, S., and Stayton, P. S. (2005) Design and development of polymers for gene delivery. Nat. Rev. Drug Discovery 4, 581-593 (Pubitemid 40975711)
18. Tanaka, T., Fillmore, D., Sun, S.-T., Nishio, I., Swislow, G., and Shah, A. (1980) Phase transitions in ionic gels. Phys. Rev. Lett. 45, 1636-1639
19. Chen, G., and Hoffman, A. S. (1995) Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH. Nature 373, 49-52.
20. Yoshida, R., Uchida, K., Kaneko, Y., Sakai, K., Kikuchi, A., Sakurai, Y., and Okano, T. (1995) Comb-type grafted hydrogels with rapid de-swelling response to temperature changes. Nature 374, 240-242
21. Stayton, P. S., Shimoboji, T., Long, C., Chilkoti, A., Chen, G., Harris, J. M., and Hoffman, A. S. (1995) Control of protein-ligand recognition using a stimuli-responsive polymer. Nature 378, 472-474 (Pubitemid 3003777)
22. Suzuki, A., and Tanaka, T. (1990) Phase transition in polymer gels induced by visible light. Nature 346, 345-347. (Pubitemid 120005895)
23. Kwon, I. C., Bae, Y. H., and Kim, S. W. (1991) Electrically erodible polymer gel for controlled release of drugs. Nature 354, 291-293
24. Osada, Y., Okuzaki, H., and Hori, H. (1992) A polymer gel with electrically driven motility. Nature 355, 242-244
25. Tanaka, T., Nishio, I., Sun, S. T., and Ueno-Nishio, S. (1982) Collapse of gels in an electric field. Science 218, 467-469
26. Miyata, T., Asami, N., and Uragami, T. (1999) A reversibly antigen-responsive hydrogel. Nature 399, 766-769
27. Petka, W. A., Hardin, J. L., McGrath, K. P., Wirtz, D., and Tirrell, D. A. (1998) Reversible hydrogels from self-assembling artificial proteins. Science 281, 389-392. (Pubitemid 28340778)
28. Wang, C., Stewart, R. J., and Kopecek, J. (1999) Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature 397, 417-420. (Pubitemid 29078904)
29. Ehrick, J. D., Deo, S. K., Browning, T. W., Bachas, L. G., Madou, M. J., and Daunert, S. (2005) Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat. Mat. 4, 298-302. (Pubitemid 40450209)
30. Obaidat, A. A., and Park, K. (1996) Characterization of glucose dependent gel-sol phase transition of the polymeric glucose-concanavalin A hydrogel system. Pharm. Res. 13, 989-995.
31. Schneider, J. P., Pochan, D. J., Ozbas, B., Rajagopal, K., Pakstis, L., and Kretsinger, J. (2002) Responsive Hydrogels from the Intramolecular Folding and Self-Assembly of a Designed Peptide. J. Am. Chem. Soc. 124, 15030-15037. (Pubitemid 36014111)
32. Collier, J. H., Hu, B.-H., Ruberti, J. W., Zhang, J., Shum, P., Thompson, D. H., and Messersmith, P. B. (2001) Thermally and photochemically triggered self-assembly of peptide hydrogels. J. Am. Chem. Soc. 123, 9463-9464. (Pubitemid 32900325)
33. Nowak, A. P., Breedveld, V., Pakstis, L., Ozbas, B., Pine, D. J., Pochan, D., and Deming, T. J. (2002) Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417, 424-428. (Pubitemid 34563531)
34. Sperinde, J. J., and Griffith, L. G. (1997) Synthesis and characterization of enzymically-crosslinked poly(ethylene glycol) hydrogels. Macromolecules 30, 5255-5264. (Pubitemid 127564780)
35. Sperinde, J. J., and Griffith, L. G. (2000) Control and prediction of gelation kinetics in enzymatically cross-linked poly(ethylene glycol) hydrogels. Macromolecules 33, 5476-5480.
36. Hu, B.-H., and Messersmith, P. B. (2003) Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels. J. Am. Chem. Soc. 125, 14298-14299.
37. Collier, J. H., and Messersmith, P. B. (2003) Enzymatic modification of self-assembled peptide structures with tissue transglutaminase. Bioconjugate Chem. 14, 748-755.
38. Sakiyama-Elbert, S. E., and Hubbell, J. A. (2000) Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J. Controlled Release 69, 149-158.
39. Wood, M. D., and Sakiyama-Elbert, S. E. (2008) Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. J. Biomed. Mater. Res. 84, 300-312
40. Willerth, S. M., and Sakiyama-Elbert, S. E. (2007) Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Delivery Rev. 59, 325-338 (Pubitemid 46879972)
41. Taylor, S. J., and Sakiyama-Elbert, S. E. (2006) Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J. Controlled Release 116, 204-210 (Pubitemid 44854282)
42. Sakiyama-Elbert, S. E., and Hubbell, J. A. (2000) Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Controlled Release 65, 389-402.
43. Stevenson, M. (2004) Therapeutic potential of RNA interference. New Engl. J. Med. 351, 1772-1777.
44. Raoul, C., Abbas-Terki, T., Bensadoun, J. C., Guillot, S., Haase, G., Szulc, J., Henderson, C. E., and Aebischer, P. (2005) Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat. Med. 11, 423-428 (Pubitemid 40562333)
45. Raoul, C., Barker, S. D., and Aebischer, P. (2006) Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther. 13, 487-495
46. Carlson, M. E., Hsu, M., and Conboy, I. M. (2008) Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532
47. Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., Vaish, N., Zinnen, S., Vargeese, C., Bowman, K., Shaffer, C. S., Jeffs, L. B., Judge, A., MacLachlan, I., and Polisky, B. (2005) Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002-1007. (Pubitemid 41114035)
48. Dykxhoorn, D. M., Chowdhury, D., and Lieberman, J. (2008) RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv. Exp. Med. Biol. 615, 299-329.
49. Dykxhoorn, D. M., and Lieberman, J. (2006) Knocking down disease with siRNAs. Cell 126, 231-235
50. Mirkin, C. A., Letsinger, R. L., Mucic, R. C., and Storhoff, J. J. (1996) A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382, 607-609.
51. Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., and Mirkin, C. A. (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 1027-1030. (Pubitemid 43752907)
52. Hurst, S. J., Lytton-Jean, A. K. R., and Mirkin, C. A. (2006) Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem. 78, 8313-8318.
53. Kim, E.-Y., Stanton, J., Vega, R. A., Kunstman, K. J., Mirkin, C. A., and Wolinsky, S. M. (2006) A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles. Nucleic Acids Res. 34, e54/1-e54/7. (Pubitemid 44314214)
54. Akinc, A., Thomas, M., Klibanov, A. M., and Langer, R. (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657-663 (Pubitemid 40744532)
55. Palliser, D., Chowdhury, D., Wang, Q. Y., Lee, S. J., Bronson, R. T., Knipe, D. M., and Lieberman, J. (2006) An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89-94. (Pubitemid 43053634)
56. Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., Hagstrom, J. E., and Wolff, J. A. (2007) Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 104, 12982-12987 (Pubitemid 351737577)
57. Wolff, J. A., and Rozema, D. B. (2008) Breaking the bonds: non-viral vectors become chemically dynamic. Mol. Therapeutics 16, 8-15.
58. Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., Borodovsky, A., Borland, T., Constien, R., de Fougerolles, A., Dorkin, J. R., Narayanannair Jayaprakash, K., Jayaraman, M., John, M., Koteliansky, V., Manoharan, M., Nechev, L., Qin, J., Racie, T., Raitcheva, D., Rajeev, K. G., Sah, D. W., Soutschek, J., Toudjarska, I., Vornlocher, H. P., Zimmermann, T. S., Langer, R., and Anderson, D. G. (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561-569 (Pubitemid 351668042)
59. Zimmermann, T. S., Lee, A. C., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., Judge, A. D., Lam, K., McClintock, K., Nechev, L. V., Palmer, L. R., Racie, T., Rohl, I., Seiffert, S., Shanmugam, S., Sood, V., Soutschek, J., Toudjarska, I., Wheat, A. J., Yaworski, E., Zedalis, W., Koteliansky, V., Manoharan, M., Vornlocher, H. P., and MacLachlan, I. (2006) RNAi-mediated gene silencing in non-human primates. Nature 441, 111-114 (Pubitemid 43827961)
60. Zintchenko, A., Philipp, A., Dehshahri, A., and Wagner, E. (2008) Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjugate Chem. 19, 1448-1455 (Pubitemid 352032345)
61. Um, S. H., Lee, J. B., Park, N., Kwon, S. Y., Umbach, C. C., and Luo, D. (2006) Enzyme-catalysed assembly of DNA hydrogel. Nat. Mat. 5, 797-801.
62. Nagahara, S., and Matsuda, T. (1996) Hydrogel formation via hybridization of oligodeoxyribonucleotides derivatized in water-soluble vinyl polymers. Polym. Gels Networks 4, 111-127. (Pubitemid 126412194)
63. Lin, D. C., Yurke, B., and Langrana, N. A. (2004) Mechanical properties of a reversible, DNA-crosslinked polyacrylamide hydrogel. J. Biomech. Eng. 126, 104-110 (Pubitemid 38649198)
64. Crank, J. (1975) The Mathematics of Diffusion, 2nd ed., Oxford University Press, Oxford.
65. Ali, M., Horikawa, S., Venkatesh, S., Saha, J., Hong, J. W., and Byrne, M. E. (2007) Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J. Controlled Release 124, 154-162 (Pubitemid 350110488)
66. Ritger, P. L., and Peppas, N. A. (1987) A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks. J. Controlled Release 5, 23-36.
67. Ritger, P. L., and Peppas, N. A. (1987) A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Controlled Release 5, 37-42.
68. Holowachuk, E. W., and Ruhoff, M. S. (1995) Efficient gene synthesis by Klenow assembly/extension-Pfu polymerase amplification (KAPPA) of overlapping oligonucleotides. PCR Methods Appl. 4, 299-302.
69. Sherlin, L. D., Bullock, T. L., Nissan, T. A., Perona, J. J., Lariviere, F. J., Uhlenbeck, O. C., and Scaringe, S. A. (2001) Chemical and enzymatic synthesis of tRNAs for high-throughput crystallization. RNA 7, 1671-1678 (Pubitemid 33078940)
70. England, T. E., and Uhlenbeck, O. C. (1978) 3′-Terminal labelling of RNA with T4 RNA ligase. Nature 275, 560-561
71. England, T. E., Bruce, A. G., and Uhlenbeck, O. C. (1980) Specific labeling of 3′ termini of RNA with T4 RNA ligase. Methods Enzymol. 65, 65-74.
72. Rehman, F. N., Audeh, M., Abrams, E. S., Hammond, P. W., Kenney, M., and Boles, T. C. (1999) Immobilization of acrylamide-modified oligonucleotides by co-polymerization. Nucleic Acids Res. 27, 649-655.
73. Nathans, D., and Smith, H. O. (1975) Restriction endonucleases in the analysis and restructuring of DNA molecules. Annu. Rev. Biochem. 44, 273-293
74. Engler, L. E., Sapienza, P., Dorner, L. F., Kucera, R., Schildkraut, I., and Jen-Jacobson, L. (2001) The energetics of the interaction of BamHI endonuclease with its recognition site GGATCC. J. Mol. Biol. 307, 619. (Pubitemid 33027681)
75. SantaLucia, J., Jr., and Hicks, D. (2004) The thermodynamics of DNA structural motifs. Annu. Rev. Biophys. Biomol. Struct. 33, 415-440
76. Santoro, S. W., and Joyce, G. F. (1997) A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. U.S.A. 94, 4262-4266
77. Santoro, S. W., and Joyce, G. F. (1998) Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 37, 13330-13342
78. Unwalla, H., and Banerjea, A. C. (2001) Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression. Antiviral Res. 51, 127-139 (Pubitemid 32592501)
79. Unwalla, H., and Banerjea, A. C. (2001) Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA. Biochem. J. 357, 147-155 (Pubitemid 32642912)
80. Kim, K., and Liu, F. (2007) Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences. Biochim. Biophys. Acta Gene Struct. Expression 1769, 603. (Pubitemid 350101863)
81. Yuan, Y., and Altman, S. (1994) Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P. Science 263, 1269-1273 (Pubitemid 24107545)
82. Ma, M., Benimetskaya, L., Lebedeva, I., Dignam, J., Takle, G., and Stein, C. A. (2000) Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat. Biotechnol. 18, 58-61. (Pubitemid 30041173)
83. Floyd-Smith, G., Slattery, E., and Lengyel, P. (1981) Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease. Science 212, 1030-1032 (Pubitemid 11078012)
84. Wreschner, D. H., McCauley, J. W., Skehel, J. J., and Kerr, I. M. (1981) Interferon action-sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature 289, 414-417
85. Shapiro, R., Fett, J. W., Strydom, D. J., and Vallee, B. L. (1986) Isolation and characterization of a human colon carcinoma-secreted enzyme with pancreatic ribonuclease-like activity. Biochemistry 25, 7255-7264 (Pubitemid 17220433)
86. Hofsteenge, J., Moldow, C., Vicentini, A. M., Zelenko, O., Jarai-Kote, Z., and Neumann, U. (1998) A single amino acid substitution changes ribonuclease 4 from a uridine-specific to a cytidine-specific enzyme. Biochemistry 37, 9250. (Pubitemid 28307678)
87. Peppas, N. A., Bures, P., Leobandung, W., and Ichikawa, H. (2000) Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 27-46.